相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer
Thiago Vidotto et al.
MOLECULAR CYTOGENETICS (2018)
BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity
Nozomi Nakajima et al.
BRAIN PATHOLOGY (2018)
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel
Angela Zacher et al.
BRAIN PATHOLOGY (2017)
Insights From Molecular Profiling of Adult Glioma
Phedias Diamandis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The biology and mathematical modelling of glioma invasion: a review
J. C. L. Alfonso et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2017)
Glioma Subclassifications and Their Clinical Significance
Ricky Chen et al.
NEUROTHERAPEUTICS (2017)
Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma
Mari Kogiso et al.
ONCOTARGET (2017)
FXR1 regulates transcription and is required for tumor growth in TP53 homozygous deletion human cancers
Yichao Fan et al.
ELIFE (2017)
Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing
Victoria K. Hill et al.
PLOS ONE (2017)
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M
Michael Karsy et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial
Hendrikus J. Dubbink et al.
NEURO-ONCOLOGY (2016)
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
Marina N. Nikiforova et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
Yu Liu et al.
NATURE (2016)
In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
C. G. Picanco-Albuquerque et al.
VIRCHOWS ARCHIV (2016)
Copy Number Profiling of Brazilian Astrocytomas
Lucas Tadeu Bidinotto et al.
G3-GENES GENOMES GENETICS (2016)
BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
Matthew Mistry et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
CDKN2A Loss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II-III) Astrocytomas
Gerald F. Reis et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index
Suvendu Purkait et al.
NEUROPATHOLOGY (2015)
Mapping p53 Mutations in Low-Grade Glioma: A Voxel-Based Neuroimaging Analysis
Y. Y. Wang et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Revisiting TP53 Mutations and Immunohistochemistry-A Comparative Study in 157 Diffuse Gliomas
Hirokazu Takami et al.
BRAIN PATHOLOGY (2015)
Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples
Tijana Stankovic et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Mutational profiling of kinases in glioblastoma
Fonnet E. Bleeker et al.
BMC CANCER (2014)
TP53 Promoter Methylation in Primary Glioblastoma: Relationship with TP53 mRNA and Protein Expression and Mutation Status
Dorota Jesionek-Kupnicka et al.
DNA AND CELL BIOLOGY (2014)
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer
Martina Kluth et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas
Nesrin Sabha et al.
NEURO-ONCOLOGY (2014)
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas
Jane B. Cryan et al.
ONCOTARGET (2014)
PTEN C-Terminal Deletion Causes Genomic Instability and Tumor Development
Zhuo Sun et al.
CELL REPORTS (2014)
CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry
Suvendu Purkait et al.
NEUROPATHOLOGY (2013)
The Nature and Timing of Specific Copy Number Changes in the Course of Molecular Progression in Diffuse Gliomas: Further Elucidation of Their Genetic Life Story
Judith W. M. Jeuken et al.
BRAIN PATHOLOGY (2011)
Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
Ahmed Idbaih et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
A. M. Halldorsdottir et al.
LEUKEMIA (2011)
Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: A prospective translational study on a uniformly treated cohort of adult patients
Mallavarapu R. Srividya et al.
NEUROPATHOLOGY (2011)
Molecular diagnostics of gliomas: state of the art
Markus J. Riemenschneider et al.
ACTA NEUROPATHOLOGICA (2010)
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
Jitka Malcikova et al.
BLOOD (2009)
Molecular biology of unreresectable meningiomas: Implications for new treatments and review of the literature
Jay Jagannathan et al.
SKULL BASE-AN INTERDISCIPLINARY APPROACH (2008)
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
John K. Wiencke et al.
NEURO-ONCOLOGY (2007)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
The INK4A/ARF locus:: Role in cell cycle control and apoptosis and implications for glioma growth
SM Ivanchuk et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
分享论文
